Heparanase is a heparan sulfate (HS) degrading endoglucuronidase that has been implicated in cell migration and inflammatory conditions. Here we used mice deficient of heparanase (Hpse -/-) 
Introduction
Heparan sulfate proteoglycans (HSPGs) consist of protein cores to which sulfated and thereby negatively charged glycosaminoglycans (GAGs) of heparan sulfate (HS) type are attached. HSPGs are ubiquitously expressed, being present on the cell surface of most cell types as well as being one of the main components of the extracellular matrix (ECM). Cell surface HSPGs, e.g. of the syndecan or glypican families (Alexopoulou et al., 2007; Filmus et al., 2008) , mediate cell-cell and cellmatrix contacts and function as co-receptors for various growth factors (Mythreye and Blobe, 2009 ). In addition, cell surface HSPGs lining the vascular endothelium act as sites for leukocyte attachment, thereby facilitating migration of blood-borne cells into tissues (Wang et al., 2005) .
Heparanase is an endoglucuronidase that cleaves HS chains (Pikas et al., 1998) .
Heparanase may thus modify the structure of preformed HSPGs and hence regulate the plethora of processes in which HSPGs are implicated. Indeed, previous studies have suggested a role for heparanase in various pathophysiological conditions, including tumor metastasis (Escobar Galvis et al., 2007; Vlodavsky and Friedmann, 2001) , experimental autoimmune disease (Lider et al., 1989) , amyloidosis (Li et al., 2005) and delayed type hypersensitivity (DTH) reactions . A role for heparanase in tumour metastasis is supported by the strong correlation between levels of heparanase expression and metastatic potential of B16 melanoma (Vlodavsky et al., 1999) and T lymphoma (Goldshmidt et al., 2002b) cells. Further, it has been shown by RNA interference that suppression of heparanase expression ameliorates DTH reactions as well as reduces lung colonization of B16 melanoma cells (Edovitsky et al., 2004) . The role of heparanase in normal cell and tissue physiology is however not well characterized, although a role in tissue remodeling, vascularization and hair growth has been suggested applying transgenic mice overexpressing heparanase .
It is important to point out that most of the functional implications for heparanase have been derived from correlative or in vitro observations, and that detailed investigations of the in vivo function of heparanase have been hampered by the lack of relevant tools. The recent generation of a mouse strain lacking heparanase expression has opened new possibilities for determining its in vivo function (Zcharia et al., 2009) . Heparanase deficient (Hpse -/-) mice do not demonstrate any major abnormalities under normal conditions, possibly due to an increased expression of matrix metalloproteases, compensating for the loss of heparanasemediated ECM degradation (Zcharia et al., 2009) . Moreover, heparanase deficiency results in accumulation of non-degraded HS chains in different tissues.
Heparanase is highly expressed by numerous types of tumor cells, and by various cells of the immune system (Vlodavsky et al., 1992) , including mast cells (Gong et al., 2003) , eosinophils (Temkin et al., 2004) , dendritic cells (Benhamron et al., 2006) and monocytes/macrophages (Sasaki et al., 2004) . However, the role of heparanase in the context of immune cell function is only partially understood.
Here we addressed this issue by studying the impact of heparanase deficiency on various leukocyte populations present in airways. We show that the absence of heparanase does not affect homing of lymphocytes or macrophages into the airways, nor does it affect lymphocyte morphology. However, lack of heparanase caused an accumulation of Ym1, a chitinase-like protein, accompanied by a striking appearance of intracellular crystalline bodies in alveolar macrophages.
Moreover, the HS chains in heparanase mutant macrophages were longer than in WT macrophages. Together, these findings implicate heparanase in the regulation of macrophage homeostasis.
Materials and Methods

Mice and collection of bronchoalveolar lavage
Heparanase-deficient (Hpse -/-) mice were generated as described (Zcharia et al., 2009 ) and were bred and maintained in the animal facility at Uppsala Biomedical Centre. Experimental groups were age and sex matched and Hpse +/+ littermates (WT mice) were used as controls. All animal experiments were approved by the local ethical committee. Bronchoalveolar lavage (BAL) fluid was collected by rinsing the lungs twice with 1 ml HBSS. Total numbers of cells were counted and cytospin slides were prepared. In separate experiments the remaining cells were centrifuged and prepared for TEM or immunoblot analysis, and the cell-free BALsupernatants were stored in -20° until used.
Transmission electron microscopy (TEM)
BAL cells from 7 or 17 months old Hpse -/-and WT mice were pooled from 2 mice per group and prepared for TEM as described (Braga et al., 2007) . Electron micrographs were generated using a Hitachi electron microscope (Hitachi Ltd., Tokyo, Japan) (Lukinius et al., 1995) .
Differential cell count and morphology
Cytospin slides were stained with May-Grünwald/Giemsa (Merck, Darmstadt, granules were given scores (1-3) corresponding to the degree of granulation and no score (0) was given for cells lacking granules. An average score per counted cell was determined. To evaluate the presence of highly sulfated GAGs, cells were stained with Toluidine blue or Alcian blue as described (Braga et al., 2007; Reimer et al., 2006) .
Immunocytochemistry
For immunocytochemistry, cytospin slides were fixed in ice-cold acetone for 5 penicillin, 60 µg/ml streptomycin and 2mM L-glutamine). Non-adherent cells, including monocyte precursors, were collected and 3x10 5 cells/ml were added to Petri dishes and cultured for 10 days in complete medium before used in further analyses.
FACS analysis
To confirm the purity of bone marrow derived macrophages, flow cytometry was used to identify presence of cells expressing the macrophage marker CD11b. Cells were washed twice in PBS and diluted in flow cytometry buffer (0.5%FCS/PBS).
Samples of 0.2 x 10 6 cells were stained for 30 minutes on ice with 0.5µg PElabeled anti-CD11b antibodies or with 0.5µg PE-labeled isotype controls (ImmunoTools, Friesoythe, Germany). After washing two times, cells were analyzed using a FACScan® flow cytometer and the CELLQuest TM 3.3 software (Becton Dickinson, San Jose, CA, USA).
Biosynthetic labeling and analysis of HS
Bone marrow derived macrophages from WT or Hpse -/-mice were cultured at 0.56x10 6 cells/ml in sulfate free medium supplemented with 2 mM L-glutamine, 1% pest, 10% L929-conditioned medium, 10% FCS (dialyzed against PBS), and 100 µCi/ml Na 35 SO 4 (specific activity 1,500 Ci/mmol; PerkinElmer, Waltham, MA, USA). After 24 hours, HS was isolated from medium or cell lysates as described (Escobar Galvis et al., 2007) . The purified 35 S-labeled HS was analyzed on a superose-6 column (GE Healthcare Biosciences, Uppsala, Sweden) in a buffer of 0.5M NH 4 HCO 3 .
Immunoblot analysis
Ten µl of BAL fluid or BAL cell pellets from 13-17 months old WT or Hpse -/-mice were separated under reducing conditions on 12% SDS-PAGE gels. Proteins were subsequently blotted onto polyvinylidene difluoride membranes, followed by incubation with LI-COR blocking buffer (LI-COR Biosciences, Cambridge, UK) for 1h at room temperature. Membranes were stained o.n. at 4°C with anti-Ym1
(StemCell Technologies) antibodies diluted 1:1000 in blocking buffer. After washing with 0.1% Tween 20 in TBS, the membrane was incubated with IR Dye 800-conjugated donkey anti-rabbit Ig (LI-COR Biosciences, dilution 1:1000) in blocking buffer. Visualization and densitometry analyses were performed using Odyssey IR imaging system (LI-COR Biosciences). Data were measured as counts/mm 2 and normalized to the loading control, i.e. results are expressed as the ratio between sample value for Ym1 and the corresponding value for β-actin.
Statistical analyses
Statistical differences between WT and Hpse -/-mice were determined by MannWhitney U test, and correlations were analyzed by Spearman test, using the GraphPad Prism 4.0 (GraphPad Software, Inc, San Diego, CA, USA).
Results
Normal homing of leukocytes to airways in the absence of heparanase
Heparanase has previously been implicated in inflammatory processes and cell migration (Benhamron et al., 2006; Edovitsky et al., 2006; Sasaki et al., 2004) , although the precise impact of heparanase on leukocyte populations in vivo has not been evaluated. To address this issue, we examined the effect of heparanase deficiency on leukocytes present in bronhcoalveolar lavage (BAL) fluid. As shown in Fig 1A, 1A ). These results demonstrate that, under normal conditions, heparanase has no major impact on migration of macrophages and lymphocytes to the airway lumen.
Granule-like structures in Hpse -/-alveolar macrophages
Examination of the morphology of May-Grünwald/Giemsa-stained BAL leukocyte populations showed that Hpse -/-lymphocytes did not differ morphologically from the corresponding WT cells (not shown). In contrast, Hpse -/-macrophages showed a striking presence of purple-stained intracellular, granule-like structures, which was not seen in WT macrophages (Fig. 1B) . A systematic scoring for the presence of granule-like structures in alveolar macrophages from 3-17 months old WT and Hpse -/-mice showed that the extent of granulation correlated strongly with the age of animals, with a more pronounced granulation seen in old (i.e. 7 and 13-17 months) vs. young (i.e. 3 months) mice ( Fig. 1B and C) . Although some signs of granulation were also seen in alveolar macrophages from old WT mice, the extent and intensity of granulation was markedly higher in corresponding macrophages derived from Hpse -/-mice ( Fig. 1B and C) . Notably, granule-like structures were not seen in peritoneal macrophages from WT or Hpse -/-mice (not shown),
suggesting that this phenotype was restricted to the airways.
Potentially, the increased granulation of alveolar macrophages might be associated with accumulation of cellular HS due to the absence of heparanase. To address this possibility, we stained for sulfated GAGs using Alcian blue and Toluidine blue (Fig. 2) . Compared with peritoneal macrophages, alveolar macrophages stained more intensely with Alcian blue ( Fig. 2A) , suggesting a higher level of cellassociated GAGs in airways as compared to peritoneal macrophages. However, there was no significant difference in the staining intensity between WT and Hpse -/-macrophages. Moreover, alveolar macrophages did not demonstrate metachromatic staining with Toluidine blue (Fig. 2B ), indicating that there was no substantial accumulation of highly sulfated GAGs in these cells.
Needle-shaped crystalline bodies in Hpse -/-alveolar macrophages
To further examine the nature of the granule-like structures present in Hpse -/-macrophages, alveolar macrophages were examined by transmission electron microscopy (TEM). The TEM analysis revealed a striking morphology of electron dense and needle-shaped crystalline bodies in alveolar macrophages derived from Hpse -/-animals, structures that were totally absent in corresponding WT cells (Fig. 3 ). The crystalline bodies were surrounded by membranes, indicating that they had developed within membrane-enclosed organelles such as lysosomes, ER or Golgi.
Accumulation of Ym1 in alveolar macrophages from Hpse -/-mice
Next, we sought to identify the macrophage-associated crystalline material.
Alveolar macrophages constitutively express Ym1, a chitinase-like protein that previously has been demonstrated to exhibit a marked tendency to spontaneously form crystals in vitro (Chang et al., 2001) . Moreover, Ym1 is known to form needle-shaped intracellular crystals (Harbord et al., 2002; Nio et al., 2004 ) that closely resemble the crystals found in Hpse -/-alveolar macrophages (Fig. 3) .
Hence, one plausible scenario is that the crystalline bodies seen in Hpse -/-alveolar macrophages contain Ym1. To address this possibility, we applied immunocytochemistry to stain for Ym1 in alveolar and peritoneal macrophages from WT and Hpse -/-mice. As shown in Fig. 4A and B, alveolar macrophages from both WT and Hpse -/-mice stained positively for Ym1 whereas peritoneal macrophages were negative, in agreement with the reported absence of Ym1 in unstimulated peritoneal macrophages (Hung et al., 2002 To further substantiate the association between intracellular Ym1 and crystalline formation, we evaluated Ym1 protein levels in both the cell-and fluid-fraction of BAL from 13-17 months old mice, using immunoblot analysis. At this age there is a significant difference between WT and Hpse -/-mice in the visual appearance of intracellular crystalline material, although a low degree of granulation is also found in WT mice ( Fig 1C) . As shown in figure 4D , high amounts of cell-associated Ym1
were apparent in three out of four samples collected from Hpse -/-mice, and only in one of three samples collected from WT mice. Notably, the Hpse -/-sample with low levels of Ym1 protein was also given low scores for intracellular granulation ( Fig   4E) . In fact, this sample was given the lowest scores within the group of 13-17 months old Hpse -/-mice ( Fig 1C) and is therefore not a representative sample.
When analyzing samples from both genotypes, there was a statistically significant correlation between intracellular Ym1 levels and the amount of crystalline material in BAL cells (Fig 4E) . In contrast, extracellular Ym1 levels did not correlate with intracellular crystals (Fig 4F) and the levels of Ym1 in cell-free BAL fluid did not differ between Hpse -/-and WT mice (Fig 4D) . Collectively, these results strongly suggest that heparanase deficiency results in accumulation of Ym1 in airway macrophages and that Ym1 is the crystal-forming unit in Hpse -/-alveolar macrophages.
Non-degraded HS chains in bone marrow derived Hpse -/-macrophages
The results described above indicate that the absence of heparanase affects the homeostasis of alveolar macrophages. To study the possible involvement of macrophage HSPGs in this effect, biosynthetic labeling experiments were carried out. Because of the low number of macrophages that can be recovered from BAL fluid, the biosynthetic labeling experiments were instead performed using macrophages derived by in vitro differentiation of bone marrow precursors (bone marrow-derived macrophages; BMMØs). As shown in does not influence macrophage differentiation (Fig 5A) . Moreover, staining with May-Grünwald/Giemsa did not reveal any obvious morphological difference between BMMØs from WT and Hspe -/-mice (not shown). In contrast to the BAL macrophages, no signs of intracellular granulation were seen in Hpse -/-BMMØs.
However, as this phenotype appears to be age-dependent (see Fig. 1B and C), its absence in BMMØs after 10 days of culture is not unexpected.
Having confirmed the macrophage phenotype of BMMØs (Fig 5A) , we metabolically labeled the cells with 35 S-sulfate, followed by purification of cellassociated and secreted HS. Gel filtration analysis showed that HS chains recovered from both the cell-associated and secreted HS isolated from Hpse -/-BMMØs are longer than HS extracted from WT BMMØs (Fig. 5B) , indicating that lack of heparanase leads to accumulation of non-degraded HS chains in Hpse -/-BMMØs.
Discussion
In the present study we establish that heparanase decisively affects macrophage homeostasis. This was demonstrated by the findings that macrophages lacking heparanase contain non-degraded HS chains and that alveolar macrophages from Hpse -/-mice exhibit an age-dependent increase in granule-like structures, identified as electron dense crystalline bodies surrounded by intracellular membranes.
Moreover, the altered morphology of Hpse-/-alveolar macrophages was associated with an increased patchy staining of intracellular Ym1, a protein known to form intracellular crystals (Nio et al., 2004) .
Heparanase expression has been detected in a variety of leukocyte populations, including monocytes/macrophages, dendritic cells, neutrophils, CD4 + T cells, mast cells and eosinophils (Benhamron et al., 2006; Temkin et al., 2004; Vlodavsky et al., 1992) . Interestingly, heparanase expressed on the surface of dendritic cells and macrophages has been shown to promote migration of these cells, by degrading ECM barriers (Benhamron et al., 2006; Sasaki et al., 2004) . Moreover, heparanase can enhance cell adhesion independent of its enzymatic activity, and thereby contribute to cell motility (Goldshmidt et al., 2003; Sotnikov et al., 2004) . These findings suggest a role for heparanase in regulating leukocyte migration processes.
We therefore hypothesized that absence of heparanase may lead to defective leukocyte migration, possibly resulting in a reduced number of leukocytes in the BAL. We show, however, that the absence of heparanase does not influence these leukocyte populations adversely. Thus, it appears that under normal conditions heparanase expression is not essential for migration of leukocytes in to the airways. However, it remains to be elucidated whether heparanase influences migration of the corresponding cell types during an inflammatory reaction.
A striking and novel finding in this study was the appearance of granulated alveolar macrophages in aged mice lacking heparanase, as detected by May
Grünwald/Giemsa staining. This phenomenon was exclusively seen in the BAL macrophage population, and was totally absent in other airway leukocytes and in peritoneal macrophages. A closer examination of the macrophages by TEM revealed that the granule-like structures had a distinct electron dense needle-shaped crystalline appearance. Moreover, the TEM analysis showed that the intracellular crystalline bodies were enclosed by membranes. One possible interpretation of these findings is that the crystalline bodies are located in lysosomes, and that they arise as a consequence of impaired regulation of compounds accumulating in the lysosome due to the absence of heparanase. In line with such a possibility, heparanase has previously been identified in intracellular compartments, including late endosomes and lysosomes (Goldshmidt et al., 2002a) in which proheparanase is processed and activated (Zetser et al., 2004) . Moreover, heparanase activity is optimal at pH5-6 (Gilat et al., 1995) , further supporting a physiological function of heparanase restricted to cellular compartments having acidic pH, such as
lysosomes.
An obvious possibility would be that the crystalline bodies in Hpse -/-macrophages contain HSPGs that accumulate in lysosomes as a result of heparanase-deficiency.
However, since the absence of heparanase did not result in a substantial accumulation of cell-associated HSPGs as judged by biosynthetic labeling experiments and by basic-dye cell staining, it appears less likely that HSPGs are predominant components of the crystals. Another possibility is that accumulation of crystalline bodies is linked to the marked increase in HS chain length shown to accompany the absence of heparanase. Although we cannot precisely explain how the increased HS chain length could account for the accumulation of crystalline material, one potential scenario could be that abnormally long HS chains may serve as a support that accumulates multiple crystal-forming molecules thus facilitating crystal formation. This would be in some analogy with the proposed contribution of HSPGs to amyloid formation (Stevens and Kisilevsky, 2000) . (Chang et al., 2001 ) and intracellular crystalline bodies in vivo (Nio et al., 2004) , in particular in alveolar macrophages from aged immunodeficient mice (Guo et al., 2000; Harbord et al., 2002) . Secondly, since HS and heparin are physiological ligands to Ym1 (Chang et al., 2001) , it may be speculated that changes in HS turnover affect Ym1 aggregation and crystallization. Finally, Ym1 is selectively expressed by alveolar macrophages and immature neutrophils under normal conditions (Nio et al., 2004) and is only expressed by peritoneal macrophages upon LPS-stimulation (Hung et al., 2002) or differentiation into alternatively activated macrophages (Kreider et al., 2007; Rauh et al., 2005) . The selective expression of Ym1 in alveolar, but not peritoneal macrophages is well in line with the appearance of granule-like structures only in the former cell type. Collectively, these findings strongly suggest that Ym1 is the crystal-forming unit in Hpse -/-alveolar macrophages.
Ym1 belongs to a group of chitinase-like proteins, including Ym2 and BRP-39 in mice, and YKL-40 in humans (Bussink et al., 2007) . Increased expression of these proteins has been associated with inflammatory diseases, in particular with allergic asthma (reviewed in (Lee et al., 2008; Shuhui et al., 2009 ). The physiological function of Ym1 is not clear, but a role in eosinophil chemotaxis (Owhashi et al., 2000) and promotion of cytokine production (Cai et al., 2009 ) has been suggested.
Interestingly, Ym1 has been reported to exhibit a weak ability to cleave Nacetylglucosamine units (Guo et al., 2000; Harbord et al., 2002) , suggesting that Ym1 may not only bind to HS but can possibly also cleave HS, and thus function in a manner similar to heparanase. However, the ability of Ym1 to process HS remains to be established.
In conclusion, the present study indicates that heparanase has a physiological role in airway cell homeostasis, by regulating the morphology of alveolar macrophages and by controlling the levels of intracellular Ym1. Considering the findings presented here and the implication of heparanase in inflammatory processes in general , it may be anticipated that heparanase has a role in the regulation of airway inflammatory diseases. in Hpse -/-alveolar macrophages from 3 (n=3), 7 (n=11; pooled from 3 independent experiments) and 13-17 (n=6; pooled from 2 independent experiments) months old mice. The extent of granulation was quantified by blinded scoring and the results are presented as mean scores ± SEM (C). Statistical differences were determined by Mann-Whitney U test: ***, P < 0.001; *, P < 0.05; not significant (ns), P > 0.05. ratios between samples and the corresponding β-actin loading control (E, F).
Figure captions
Amounts of intracellular granule-like structures were analyzed by blinded scoring of May-Grünwald/Giemsa-stained cells and were plotted against corresponding densitometry values (E, F). The degree of granulation was significantly associated with intracellular Ym1 levels (E) but not with extracellular Ym1 levels (F) in BAL, as determined by Spearman correlation test (P < 0.05). 
